INS and Alzheimer disease: However, more recently, in a randomized clinical trial of 289 adults with mild cognitive impairment or AD, the intranasal insulin treatment showed no cognitive or functional benefits for the patients [70], but the limitation in this study was that the device used for intranasal insulin supply had not been tested before.